ALPS Medical Breakthroughs ETF Rating → Exposed: 10 CENT Crypto to Explode May 20th? (From True Market Insiders) (Ad) Free SBIO Stock Alerts $34.38 -0.44 (-1.26%) (As of 05/8/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings ALPS Medical Breakthroughs ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SBIO Aggregate RatingModerate Buy2.81Holdings in SBIO have an aggregate rating of Moderate Buy based on 397 analyst ratings issued in the past year covering 50 companies (84.1% of the portfolio).SBIO Aggregate Price Target$50.5547.04% UpsideHigh Prediction$67.18Average Prediction$50.55Low Prediction$35.10Holdings in SBIO have an aggregate price target of $50.55 and a range of $35.10 to $67.18 covering 50 companies (84.1% of the portfolio).SBIO Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy24 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ALPS Medical Breakthroughs ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 SBIO Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.30%VKTXViking Therapeutics$79.91+0.4%4 of 5 stars3.00$112.25 40.5%105.25%CERECerevel Therapeutics$42.06-0.5%0 of 5 stars2.11$42.67 1.4%9Positive News4.47%PCVXVaxcyte$66.79-1.1%1 of 5 stars3.00$78.50 17.5%4Upcoming EarningsNews Coverage4.03%RVMDRevolution Medicines$38.31-1.5%3 of 5 stars3.10$41.20 7.5%10Gap Down2.88%ALPNAlpine Immune Sciences$64.70+0.1%2 of 5 stars2.27$50.33 -22.2%112.81%ALKSAlkermes$24.10-2.0%5 of 5 stars2.50$35.38 46.8%10Analyst Revision2.31%AXSMAxsome Therapeutics$75.68-1.6%4 of 5 stars2.92$121.92 61.1%13Analyst ForecastAnalyst RevisionNews Coverage2.29%SWTXSpringWorks Therapeutics$42.26-7.6%1 of 5 stars3.00$68.83 62.9%6Earnings ReportAnalyst ForecastAnalyst Revision2.23%CRNXCrinetics Pharmaceuticals$50.89+6.8%4 of 5 stars2.92$57.58 13.2%12Analyst ForecastNews CoverageGap UpHigh Trading Volume2.08%XENEXenon Pharmaceuticals$42.93-1.2%2 of 5 stars3.00$59.44 38.5%9News Coverage2.00%IDYAIDEAYA Biosciences$41.41-3.1%3 of 5 stars3.00$47.50 14.7%12Earnings ReportAnalyst ForecastNews CoverageGap Down1.98%IMCRImmunocore$61.32+0.5%3 of 5 stars2.87$80.92 32.0%15Analyst RevisionNews CoverageGap Down1.87%ACADACADIA Pharmaceuticals$17.13-0.7%4 of 5 stars2.80$31.75 85.3%15Analyst ForecastNews Coverage1.86%ACLXArcellx$52.25-0.3%3 of 5 stars3.00$75.64 44.8%12Upcoming EarningsAnalyst Forecast1.84%SMMTSummit Therapeutics$4.96-6.6%2 of 5 stars3.00$7.50 51.2%2Analyst Forecast1.77%MRUSMerus$47.09-3.4%1 of 5 stars3.00$56.33 19.6%11Earnings ReportNews Coverage1.73%MLTXMoonLake Immunotherapeutics$42.63-2.4%3 of 5 stars2.75$74.46 74.7%12Earnings ReportUpcoming EarningsAnalyst ForecastNews Coverage1.61%CORTCorcept Therapeutics$25.40+3.8%5 of 5 stars3.00$40.10 57.9%4Insider SellingAnalyst Revision1.59%CLDXCelldex Therapeutics$41.21-2.4%1 of 5 stars2.80$66.00 60.2%5Analyst ForecastAnalyst RevisionNews Coverage1.57%RYTMRhythm Pharmaceuticals$38.92-1.1%3 of 5 stars2.83$54.33 39.6%6Earnings ReportAnalyst ForecastNews CoverageGap Down1.51%VCELVericel$47.69-3.7%1 of 5 stars3.00$46.40 -2.7%6News CoverageGap Down1.50%ARVNArvinas$32.37-5.7%3 of 5 stars2.88$61.33 89.5%16Earnings ReportAnalyst ForecastNews CoverageGap Down1.48%VERAVera Therapeutics$44.94-0.1%1 of 5 stars3.00$32.29 -28.2%81.46%DNLIDenali Therapeutics$18.90+12.2%4 of 5 stars2.89$40.22 112.8%9Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume1.42%KROSKeros Therapeutics$58.24-0.7%3 of 5 stars3.00$86.00 47.7%7News CoverageGap Down1.41%GERNGeron$3.81-1.6%4 of 5 stars2.80$6.10 60.1%5Analyst Revision1.36%NTLAIntellia Therapeutics$23.00-3.7%4 of 5 stars2.69$67.00 191.3%13Gap Down1.32%RNAAvidity Biosciences$26.06+2.6%1 of 5 stars3.00$36.86 41.4%7Upcoming EarningsInsider SellingNews Coverage1.30%GLPGGalapagos$29.03-0.2%0 of 5 stars1.75$34.50 18.8%41.22%SNDXSyndax Pharmaceuticals$22.38-3.5%3 of 5 stars2.90$34.42 53.8%10News CoverageGap Down1.20%AGIOAgios Pharmaceuticals$32.46-1.0%1 of 5 stars2.50$35.00 7.8%4Earnings ReportAnalyst Revision1.19%CPRXCatalyst Pharmaceuticals$14.72-2.8%5 of 5 stars3.00$26.43 79.5%5News Coverage1.10%INBXInhibrx$34.44+0.1%3 of 5 stars2.00$27.00 -21.6%2Upcoming EarningsNews CoveragePositive News1.07%ZLABZai Lab$16.57-0.7%2 of 5 stars3.00$64.22 287.6%5Positive News1.02%EWTXEdgewise Therapeutics$20.89-1.6%1 of 5 stars3.00$31.20 49.4%51.02%KURAKura Oncology$20.55-2.5%3 of 5 stars2.88$28.28 37.6%8Earnings ReportAnalyst Forecast1.00%PTGXProtagonist Therapeutics$27.11+5.1%2 of 5 stars3.00$38.00 40.2%4Analyst ForecastNews Coverage0.96%RCUSArcus Biosciences$15.24-2.1%2 of 5 stars2.88$41.25 170.7%8News CoverageGap Down0.96%MORFMorphic$29.33-2.6%3 of 5 stars2.67$51.50 75.6%6Positive News0.95%NMRANeumora Therapeutics$9.42-4.0%1 of 5 stars2.86$22.57 139.6%7Earnings Report0.89%DAWNDay One Biopharmaceuticals$16.41-3.9%3 of 5 stars2.86$37.67 129.5%7Analyst ForecastAnalyst RevisionNews Coverage0.85%VRNAVerona Pharma$14.88+0.6%2 of 5 stars3.00$33.60 125.8%4News Coverage0.83%IRWDIronwood Pharmaceuticals$8.124 of 5 stars3.00$19.80 143.8%50.83%XNCRXencor$23.66-2.4%4 of 5 stars2.89$36.00 52.2%9Upcoming Earnings0.82%TARSTarsus Pharmaceuticals$37.35-1.8%3 of 5 stars2.88$48.38 29.5%8News Coverage0.81%DCPHDeciphera Pharmaceuticals$25.370.0%3 of 5 stars2.30$24.17 -4.7%10Analyst Revision0.79%SLNOSoleno Therapeutics$46.26-1.2%4 of 5 stars3.00$55.60 20.2%5Upcoming Earnings0.79%FDMT4D Molecular Therapeutics$26.33-1.8%2 of 5 stars3.00$44.22 68.0%10Gap Down0.78%MNKDMannKind$4.40-1.6%2 of 5 stars3.00$8.00 81.8%3Earnings ReportNews Coverage0.78%MIRMMirum Pharmaceuticals$25.04-3.4%4 of 5 stars3.11$51.70 106.5%9 This page (NYSEARCA:SBIO) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm PressObama’s Forever Term [exposed]Porter & CompanyPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society“Crash Insurance” For Your RetirementUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
